Results 181 to 190 of about 275,854 (308)

Evaluation of Maternal Serum Amyloid A as a Biomarker for Preeclampsia

, 2023
Ola Hussain Ashoor El-Attabi, Hala Abdulghani Al-Rawi   +1 more
openalex   +1 more source

Analysis of Single Particles of Amyloid Beta and α‐Synuclein With Seeded Amplification for the Diagnosis of Alzheimer's and Parkinson's Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by the pathological aggregation of specific proteins such as amyloid beta (Aβ) and α‐synuclein, respectively. Early detection of these protein aggregates in biological fluids could facilitate timely diagnosis and therapeutic ...
Alexandra Dybala, Marlene Pils, Oliver Bannach, Gültekin Tamgüney, Detlev Riesner   +4 more
wiley   +1 more source

The Inflammatory Role of Serum Amyloid A in the Pathogenesis and Progression of Diabetic Nephropathy. [PDF]

J Clin Med
Stavrou A, Kousparou CA, Tsakalis A.
europepmc   +1 more source

Reduced serum miR‐202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein

, 2021
Li‐Hua Dong, Lei Sun, Wenjing Zhang, Xiaoyan Wang, Jia‐Mei Li   +4 more
openalex   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

Re: Comments on "Elevated Serum Amyloid A2 and A4 in Patients With Guillain-Barré Syndrome". [PDF]

J Clin Neurol
Wang Y.
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Serum Amyloid A and Haptoglobin as Markers in Cats with Gingivitis-Preliminary Study. [PDF]

Vet Med Sci
Oikonomidis IL, Kavarnos I, Papadimitriou S, Ceron JJ, Kouki M, Adamama-Moraitou KK, Soubasis N.   +6 more
europepmc   +1 more source

Regulation of Extrahepatic Apolipoprotein Serum Amyloid A (ApoSAA) Gene Expression by Interleukin‐1α Alone: Synthesis and Secretion of ApoSAA by Cultured Aortic Smooth Muscle Cells [PDF]

, 1997
Yoshitaka Kumon, Jean D. Sipe, Constance Brinckerhoff, Barbara M. Schreiber   +3 more
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source